Abstract
With the introduction of direct-acting antiviral drugs, treatment of hepatitis C is both highly effective and tolerable. Access to treatment for patients, however, remains limited in low- and middle-income countries due to the lack of supportive health infrastructure and the high cost of treatment. Poorer countries are being encouraged by international bodies to organize public health responses that would facilitate the roll-out of care and treatment on a national scale. Yet few countries have documented formal plans and policies. Here, we outline the approach taken in Rwanda to a public health framework for hepatitis C control and care within the World Health Organization hepatitis health sector strategy. This includes the development and implementation of policies and programmes, prevention efforts, screening capacity, treatment services and strategic information systems. We highlight key successes by the national programme for the control and management of hepatitis C: establishment of national governance and planning; development of diagnostic capacity; approval and introduction of direct-acting antiviral treatments; training of key personnel; generation of political will and leadership; and fostering of key strategic partnerships. Existing challenges and next steps for the programme include developing a detailed monitoring and evaluation framework and tools for monitoring of viral hepatitis. The government needs to further decentralize care and integrate hepatitis C management into routine clinical services to provide better access to diagnosis and treatment for patients. Introducing rapid diagnostic tests to public health-care facilities would help to increase case-finding. Increased public and private financing is essential to support care and treatment services.
Highlights
Worldwide, an estimated 71 million people, 1% of the global population, are chronically infected with hepatitis C virus (HCV).[1]
43 countries have reported completion of national viral hepatitis elimination plans, very few of these are from low- and middle-income countries and even fewer are from sub-Saharan Africa.[1]
We describe the framework for a comprehensive response to the epidemic in Rwanda within the proposed framework of the World Health Organization (WHO) hepatitis health sector strategy.[7]
Summary
An estimated 71 million people, 1% of the global population, are chronically infected with hepatitis C virus (HCV).[1]. The objective was to develop a specific programme for the prevention, care and treatment of hepatitis B and C.13 In 2013, the viral hepatitis technical working group was set up, comprising health ministry specialists, clinicians, academic researchers, laboratory experts, implementing partner organizations, United Nations agencies, and civil society and private sector representatives.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.